Bri-Chem (BRY) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
22 Oct, 2026Executive summary
Q4 2023 sales were $26.8M, up $253K YoY; adjusted EBITDA rose 35% to $1.9M, while operating earnings held near $1.0M.
FY 2023 sales were $106.0M versus $104.5M; operating earnings fell 40% to $4.7M and adjusted EBITDA declined 11% to $6.6M.
Financial highlights
Q4 gross margin dollars decreased $410K YoY, primarily from higher shipping costs and pricing concessions on selected products.
Q4 adjusted net earnings were $552K versus $239K; net earnings were $467K versus $30K.
FY adjusted net earnings were $1.4M versus $3.6M; net earnings were $909K versus $8.6M.
Q4 revenue rose to $26.8M from $26.5M, as Canadian drilling fluids and blending activity offset lower US sales.
Outlook and guidance
2024 US oilfield activity is expected to remain relatively sluggish following a larger-than-expected rig count decline during FY 2023.
Selective product expansion with new and existing customers is expected to support modest growth in Canadian blending; overhead and employee levels remain controlled.
Latest events from Bri-Chem
- Sales grew 16%, but higher costs and lower margins cut adjusted EBITDA 34%.BRY
Q1 2023 - Adjusted EBITDA rose, but lower U.S. drilling sales weighed on Q2 revenue.BRY
Q2 2023 - Lower U.S. rig activity and margin pressure cut Q3 earnings; a modest 2024 recovery is possible.BRY
Q3 2023 - Lower US drilling drove a 24% sales decline and Q2 net loss.BRY
Q2 2024 - Lower drilling activity drove a 21% sales decline and a $443K Adjusted EBITDA loss.BRY
Q1 2024 - Weaker US drilling drove lower Q3 sales, earnings and Adjusted EBITDA.BRY
Q3 2024 - Lower sales and a $1.1M bad-debt write-off drove FY adjusted EBITDA negative.BRY
Q4 2024 - Lower US drilling cut sales 7%, while adjusted EBITDA returned to positive territory.BRY
Q1 2025 - Q2 earnings improved as sales rose, but Canadian demand remains soft.BRY
Q2 2025